
    
      Patients with newly diagnoised colorectal cancer will be eligible. They will undergo detailed
      history taking including family history, and molecular stuidies including microsatellite
      instability test and immunohistochemistry for DNA mismatch repair protein with pre-selection.
      Any abnormal finding in molecular stuides will be offered genetic testing (after testing
      methylation status for patients with abnormalities in MLH1).
    
  